Related Experiment Video
Updated: Jul 21, 2026

10:51
Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
Insulin-unresponsive tissues respond to superactive insulin-like material
Summary
Insulin-like material from insulin-Sepharose effectively stimulates glucose metabolism in obese mice, unlike regular insulin. This suggests a novel therapeutic potential for insulin resistance.
Area of Science:
- Biochemistry
- Metabolic Research
- Endocrinology
Background:
- Obesity and insulin resistance are significant health concerns.
- C57Bl/6J ob/ob mice exhibit a genetic model of obesity and impaired insulin signaling.
- Standard insulin therapy can be less effective in certain obese states.
Purpose of the Study:
- To investigate the differential effects of insulin-like material versus insulin on glucose metabolism.
- To assess the efficacy of insulin-like material in an obese mouse model.
Main Methods:
- Preparation of insulin-like material using insulin-Sepharose.
- Incubation of isolated diaphragm and epididymal fat tissues from C57Bl/6J ob/ob mice and lean littermates.
- Measurement of glucose oxidation rates in response to insulin and insulin-like material.
Main Results:
- Insulin-like material significantly stimulated glucose oxidation in the diaphragm of obese mice, while insulin did not.
- The insulin-like material demonstrated greater efficacy than insulin on epididymal fat tissue from obese mice.
- Insulin and insulin-like material showed equipotent effects on tissues from lean control mice.
Conclusions:
- Insulin-Sepharose-derived insulin-like material possesses enhanced bioactivity in specific tissues of obese mice.
- This material may represent a more effective therapeutic agent for conditions characterized by insulin resistance.
- Further research into the mechanism and application of this insulin-like material is warranted.
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Bioactivation and Tissue Toxicity
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...

